Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trialResearch in context

Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trialResearch in context

Summary: Background: New non-pharmacological treatments for improving non-motor symptoms in Parkinson's disease (PD) are urgently needed. Previous light therapies for modifying sleep behaviour lacked standardised protocols and were not personalised for an individual patient chronotype. We aime...

Full description

Bibliographic Details
Main Authors: Beatrix Feigl, Simon J.G. Lewis, Lucy D. Burr, Daniel Schweitzer, Subodh Gnyawali, Dimitrios Vagenas, Drew D. Carter, Andrew J. Zele
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:EClinicalMedicine
Subjects:
Melanopsin
Light
Sleep
Polysomnography
Motor
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537024000531

Internet

http://www.sciencedirect.com/science/article/pii/S2589537024000531

Similar Items